Biofrontera Reiterates FY23 Revenue Growth Expectation Of At Least 25% YoY, Expects To Be Cash Flow Positive Within Roughly One And Half Years
Portfolio Pulse from Benzinga Newsdesk
Biofrontera Inc. (NASDAQ:BFRI) has reiterated its expectation for FY23 revenue growth of at least 25% YoY. The company also expects to be cash flow positive within approximately one and a half years.
August 11, 2023 | 11:06 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Biofrontera's reaffirmation of its FY23 revenue growth and its expectation to be cash flow positive could potentially boost investor confidence.
Biofrontera's reaffirmation of its FY23 revenue growth and its expectation to be cash flow positive is a positive signal to investors. This could potentially lead to an increase in the stock price in the short term as it indicates strong financial performance and future profitability.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100